	Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a BTLA Agonist Antibody (Venanprubart) in Healthy Participants, Patients with Systemic Lupus Erythematosus, and Patients with Psoriasis: Results From Three Phase 1 Studies. Clin Pharmacol Drug Dev Vendel AC, Benichou O, Chang CY, Datta G, Ferrante A, Ghosh I, Moser BA, Sweeney SE, Witcher J, Linnik MD. PMID: 41549797 [PubMed - indexed for MEDLINE]
	Expanding the Dermatologic Horizon of GLP-1 Receptor Agonists - Response to 'Dermatologic and Metabolic Benefits of Semaglutide in Psoriasis with Obesity: A Six-Month Prospective Cohort Study'. Clin Exp Dermatol Potluru A, Nikookam Y. PMID: 41549421 [PubMed - as supplied by publisher]
	Dysregulation of caspase-8 and caspase-9 in T-lymphocyte apoptosis: implications for pathogenesis, diagnosis, and therapeutic targeting in psoriatic arthritis. BMC Mol Cell Biol Al-Rawaf HA, Gabr SA, Iqbal A, Alghadir AH. PMID: 41549289 [PubMed - as supplied by publisher]
	Efficacy and safety of vunakizumab in patients with moderate-to-severe plaque psoriasis who have a history of systemic therapies: a post hoc analysis of a phase III trial. Int Immunopharmacol Zhou J, Li S. PMID: 41547249 [PubMed - as supplied by publisher]
	Model-Based Meta-Analysis of IL-17Â A Inhibitors for Moderate-to-Severe Plaque Psoriasis: Establishing Exposure-Response Relationships to Inform Targeted Drug Development. Clin Rev Allergy Immunol Liu Y, Chen X, Xu L, Zheng Q, Li L. PMID: 41543629 [PubMed - indexed for MEDLINE]
	Abundances but not concentrations of circulating unsaturated fatty acids are associated with incident psoriatic diseases: Evidence from cohort and Mendelian randomization studies. JID Innov Shen M, Wang Z, Jing D, Yang S, Xiao Y, Chen X. PMID: 41537120 [PubMed]
	An old disease, a new linguistic challenge for large language models: patient education on psoriasis and psoriatic arthritis in an underrepresented medical language. Int J Med Inform Atilan AU, Cetin N. PMID: 41534240 [PubMed - as supplied by publisher]
	Therapeutic approach with fatty acids in psoriasis: A systematic review. Aten Primaria Pereira de Souza OK, da Silva Lisboa ML, Teixeira Alves A, Gomide Matheus LB, da Silva ML, da Costa Cunha K. PMID: 41534196 [PubMed - as supplied by publisher]
	Reprogramming immunity at the metabolic-epidermal interface in obesity-associated psoriasis. Cytokine Growth Factor Rev Jang J, Park M, Kim HJ, Jung Y. PMID: 41534195 [PubMed - as supplied by publisher]
	Impact of Variation in APOE on Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Sequencing and Genotyping in General Population Cohorts. ACR Open Rheumatol Rasmussen KL, Luo J, Nielsen SF, Nordestgaard BG, Tybjærg-Hansen A, Frikke-Schmidt R. PMID: 41533464 [PubMed]
	Bidirectional Associations Between Substance Abuse and Psoriasis: A Prospective Cohort Study. Psoriasis (Auckl) Che X, Zhou J, Wang A, Guo J, Zhang C, Xiao Y. PMID: 41531932 [PubMed]
	S3 Guideline for the treatment of psoriasis vulgaris, adapted from EuroGuiDerm - part 1: Treatment recommendations and monitoring. J Dtsch Dermatol Ges Nast A, Altenburg A, Augustin M, Bachmann F, Boehncke WH, Cornberg M, Geerdes-Fenge H, Häcker B, Härle P, Klaus J, Köhm M, Köllner A, Mrowietz U, Ockenfels HM, Pennitz A, Philipp S, Richter T, Rosenbach T, Schaberg T, Schlaeger M, Schmid-Ott G, Sebastian M, Thölken K, von Kiedrowski R, Willuhn U, Zeyen C. PMID: 41531416 [PubMed - indexed for MEDLINE]
	Exploration of shared gene signatures and molecular mechanisms between psoriasis and COVID-19: evidence from transcriptome data. Mamm Genome Dong RJ, Yang LH, Li YY, Lu YW. PMID: 41530290 [PubMed - in process]
	Impact of secukinumab with modified nourishing blood and moisturising decoction on superficial fungal infections in patients with psoriasis with blood-dryness pattern. J Wound Care Liu Q, Han L, Shi L, Mao X. PMID: 41528783 [PubMed - indexed for MEDLINE]
	Long-Term Effectiveness of Bimekizumab in Plaque Psoriasis: Two-Year Drug Survival from a Real-Life Multicenter Italian Study. Clin Exp Dermatol De Luca E, Dattola A, Artosi F, Bellinato F, Bianchi L, Burlando M, Campione E, Francesca Cavaliere A, Claudio Cozzani E, Costanzo A, Gaiani F, Gargiulo L, Gisondi P, Finistauri Guacci L, Guarino L, Loconsole F, Malagoli P, Mianulli L, Megna M, Messina F, Narcisi A, Potestio L, Tommasino N, Italian Landscape Group, PertusiClara De Simone G, Peris K, Caldarola G. PMID: 41527928 [PubMed - as supplied by publisher]
	Psoriasis outcomes following metabolic bariatric surgery - a systematic review of the literature. BMC Surg Kehagias D, Lampropoulos C, Pellen M, Abogabal S, Haider MI, Kehagias I, Jain P. PMID: 41526863 [PubMed - as supplied by publisher]
	Do Nails Tell a Pulmonary Tale? A Cross-Sectional Study on Psoriasis and Pulmonary Hypertension Risk. J Cutan Med Surg Gupta S, Chopra D. PMID: 41526803 [PubMed - as supplied by publisher]
	Role of real-world evidence from patient registries for psoriasis in decision-making: a systematic review. BMJ Open Qual Passero L, Simon TA, Zhong Y, Zhuo J, Varga S, Armstrong AW. PMID: 41526088 [PubMed - indexed for MEDLINE]
	Molecular Classification in a Cohort of Occupational Dermatological Patients: Diagnostic Results and Course of Ability to Work and Sick Leave Over Two Years. Acta Derm Venereol Bentz P, Eyerich K, Skudlik C, Schröder-Kraft C, Löffler H, Pföhler C, Leitz N, Thölken K, Weisshaar E. PMID: 41524178 [PubMed - indexed for MEDLINE]
	Persistence of interleukin-17 and interleukin-23 inhibitors in patients with plaque psoriasis: a real-world study in Taiwan. J Dermatolog Treat Huang YH, Xu Y, Chang SC, Lin YJ, Chang CL, Wu GH, Zhang Y, Wahking B, Qiu H, Chang CJ. PMID: 41521930 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 27306

Page 1 of 1366



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy